Bee Vectoring Technologies International（1UR1）株式概要ビー・ベクタリング・テクノロジーズ・インターナショナル 詳細1UR1 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析過去5年間で収益は年間1.2%減少しました。 収益が 100 万ドル未満 ( CA$115K )意味のある時価総額がありません ( €1M )株式の流動性は非常に低い +1 さらなるリスクすべてのリスクチェックを見る1UR1 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.00233.3% 割高 内在価値ディスカウントEst. Revenue$PastFuture-5m626k2016201920222025202620282031Revenue CA$285.1kEarnings CA$27.1kAdvancedSet Fair ValueView all narrativesFeatured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.0% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.8kusers have viewed this narrative41users have liked this narrative1users have commented on this narrative284users have followed this narrativeRead narrativeBee Vectoring Technologies International Inc. 競合他社Bio-GateSymbol: DB:BIG1Market cap: €7.1mPhyto Chem (India)Symbol: BSE:524808Market cap: ₹105.3mCan Tho PesticidesSymbol: HNX:CPCMarket cap: ₫69.4bMauritius Chemical and Fertilizer IndustrySymbol: MUSE:MCFI.N0000Market cap: MU₨132.0m価格と性能株価の高値、安値、推移の概要Bee Vectoring Technologies International過去の株価現在の株価CA$0.00252週高値CA$0.02252週安値CA$0.0005ベータ0.601ヶ月の変化0%3ヶ月変化300.00%1年変化-88.24%3年間の変化-98.67%5年間の変化-99.26%IPOからの変化-99.01%最新ニュースBoard Change • Dec 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Gustavo Gonzalez was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2023)Third quarter 2024 results: CA$0.006 loss per share (in line with 3Q 2023). Net loss: CA$1.18m (loss widened 41% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.お知らせ • Aug 22Bee Vectoring Technologies International Inc. Receives Mexican Approval on its Proprietary Biological for Commercial UseBee Vectoring Technologies International Inc. announced the Company's proprietary Vectorite with Clonostachys Rosea CR-7 (CR-7) has been approved by Mexico's COFEPRIS (The Federal Commission for Protection from Sanitary Risks), the country's health authority responsible for registration of plant protection products, for use as a fungicide on commercial crops. The approval covers delivery of CR-7 using both bumble bees and honeybees on various high value crops, including the berry group of crops and indoor vegetables. Mexico's growers offer significant market potential for BVT's natural precision agriculture system: official statistics indicate that the country's production in 2019 included 41,600 acres of strawberries, 12,100 acres of blueberries and over 377,000 acres of tomatoes and peppers.(1) In the same year, US imports of fresh and processed fruits and vegetables from Mexico amounted to USD 15.6 billion. The country uses USD 1.3 billion worth of pesticides each year, but an increasing number of growers are turning to biologicals as an alternative that offers better quality, greater food safety and reduces the need for chemicals. Mexico's COFEPRIS registration makes Vectorite with CR-7 available immediately for sale as a registered fungicide for use on the labelled crops.Reported Earnings • Jun 04Second quarter 2024 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2023). Revenue: CA$81.9k (down 77% from 2Q 2023). Net income: CA$20.9k (up CA$567.2k from 2Q 2023). Profit margin: 26% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 03First quarter 2024 earnings released: CA$0.011 loss per share (vs CA$0.011 loss in 1Q 2023)First quarter 2024 results: CA$0.011 loss per share (in line with 1Q 2023). Revenue: CA$17.0k (down 62% from 1Q 2023). Net loss: CA$1.65m (loss widened 12% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 53% per year, which means it is significantly lagging earnings.お知らせ • Mar 02Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024. Location: Suite 1890 1075 West Georgia Street Vancouver British Columbia Canada最新情報をもっと見るRecent updatesBoard Change • Dec 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Gustavo Gonzalez was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2023)Third quarter 2024 results: CA$0.006 loss per share (in line with 3Q 2023). Net loss: CA$1.18m (loss widened 41% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.お知らせ • Aug 22Bee Vectoring Technologies International Inc. Receives Mexican Approval on its Proprietary Biological for Commercial UseBee Vectoring Technologies International Inc. announced the Company's proprietary Vectorite with Clonostachys Rosea CR-7 (CR-7) has been approved by Mexico's COFEPRIS (The Federal Commission for Protection from Sanitary Risks), the country's health authority responsible for registration of plant protection products, for use as a fungicide on commercial crops. The approval covers delivery of CR-7 using both bumble bees and honeybees on various high value crops, including the berry group of crops and indoor vegetables. Mexico's growers offer significant market potential for BVT's natural precision agriculture system: official statistics indicate that the country's production in 2019 included 41,600 acres of strawberries, 12,100 acres of blueberries and over 377,000 acres of tomatoes and peppers.(1) In the same year, US imports of fresh and processed fruits and vegetables from Mexico amounted to USD 15.6 billion. The country uses USD 1.3 billion worth of pesticides each year, but an increasing number of growers are turning to biologicals as an alternative that offers better quality, greater food safety and reduces the need for chemicals. Mexico's COFEPRIS registration makes Vectorite with CR-7 available immediately for sale as a registered fungicide for use on the labelled crops.Reported Earnings • Jun 04Second quarter 2024 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2023). Revenue: CA$81.9k (down 77% from 2Q 2023). Net income: CA$20.9k (up CA$567.2k from 2Q 2023). Profit margin: 26% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 03First quarter 2024 earnings released: CA$0.011 loss per share (vs CA$0.011 loss in 1Q 2023)First quarter 2024 results: CA$0.011 loss per share (in line with 1Q 2023). Revenue: CA$17.0k (down 62% from 1Q 2023). Net loss: CA$1.65m (loss widened 12% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 53% per year, which means it is significantly lagging earnings.お知らせ • Mar 02Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024. Location: Suite 1890 1075 West Georgia Street Vancouver British Columbia Canadaお知らせ • Feb 01Bee Vectoring Technologies International Inc. Announces Paid Demonstration Trials in Mexico with Major Multi-National GrowerBee Vectoring Technologies International Inc. announced that a major multi-national grower is conducting demonstration trials in Mexico with BVT's proprietary Vectorite with CR-7 (Clonostachys rosea CR-7) biological fungicide and natural precision agriculture system. This multi-national grower is a key producer of blueberries, raspberries, blackberries and table grapes in Mexico. They have over 5,000 hectares worldwide for the production of berries, with additional operations in the US, Peru and Morocco. After the initial honeybee system trials in their Mexican operations, there is opportunity to expand BVT trials to the other countries. The BVT trials are staggered to the start of bloom time for each berry crop. They commenced last September with the start of blackberry and raspberry bloom periods, moved to blueberry in November, and lasts into early 2024. Trial data is being collected at each crop's harvest time and the grower is currently evaluating for yield performance and percentage of fruit spoilage with BVT and the grower standard applied versus the grower standard used alone. Geographic expansion is a key element in BVT's ongoing corporate expansion strategy. BVT's registration dossier was submitted to regulatory authorities in Mexico in April 2022, and BVT continues to build and expand strategic relationships with Mexican growers. This newest relationship with a multi-national grower with operations in Mexico is a vital step in the Company's continued development in the country.Reported Earnings • Jan 30Full year 2023 earnings released: CA$0.034 loss per share (vs CA$0.041 loss in FY 2022)Full year 2023 results: CA$0.034 loss per share (improved from CA$0.041 loss in FY 2022). Revenue: CA$601.6k (up 21% from FY 2022). Net loss: CA$4.67m (loss narrowed 5.2% from FY 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 55% per year, which means it is significantly lagging earnings.お知らせ • Jan 17Bee Vectoring Technologies International Inc. Announces South African Trials with Major Multi-National AgribusinessBee Vectoring Technologies International Inc. announced South African multi-national agricultural technology business Microbial Biological Fertilizers International (MBFi) has commenced trials of BVT products in South Africa. They will be evaluating BVT's patented bee vectoring dispenser for honeybees with proprietary Vectorite powder, initially testing with MBFi's own biological strain as a comparison with traditional spray applications. MBFi manufactures agricultural products for the South African farming industry, supplying fertilizer, biostimulants, biologicals and adjuvants. Trials are being conducted on grower crop fields including macadamias, avocados, apples, strawberries, blueberries and cherries, timed for the start of each crop's bloom period. MBFi will also extend the trials to include sunflowers and canola. In South Africa, macadamia, avocado, applies, strawberries, blueberries and cherry crops cover over 85,000 hectares of farmland, with sunflowers and canola adding another 520,000.Reported Earnings • Sep 03Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.008 loss in 3Q 2022)Third quarter 2023 results: CA$0.006 loss per share (improved from CA$0.008 loss in 3Q 2022). Revenue: CA$203.2k (up 32% from 3Q 2022). Net loss: CA$836.2k (loss narrowed 9.7% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.013 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (improved from CA$0.013 loss in 2Q 2022). Revenue: CA$360.6k (up 26% from 2Q 2022). Net loss: CA$546.3k (loss narrowed 64% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.お知らせ • May 16Bee Vectoring Technologies International Inc. announced that it has received CAD 0.27 million in fundingOn May 15, 2023, Bee Vectoring Technologies International Inc. closed the transaction. All securities issued pursuant to the transaction are subject to a statutory hold period which will expire on September 13, 2023 in accordance with applicable securities laws of Canada.Reported Earnings • Mar 03First quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.009 loss in 1Q 2022)First quarter 2023 results: CA$0.011 loss per share (further deteriorated from CA$0.009 loss in 1Q 2022). Revenue: CA$44.5k (up 11% from 1Q 2022). Net loss: CA$1.48m (loss widened 37% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.Board Change • Dec 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Jim Molyneux was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Nov 19Bee Vectoring Technologies International Inc., Annual General Meeting, Jan 19, 2023Bee Vectoring Technologies International Inc., Annual General Meeting, Jan 19, 2023.Reported Earnings • Jan 30Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: CA$0.036 loss per share (up from CA$0.078 loss in FY 2020). Revenue: CA$399.1k (up 38% from FY 2020). Net loss: CA$4.12m (loss narrowed 39% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Reported Earnings • Sep 01Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.013 loss in 3Q 2020)Third quarter 2021 results: Net loss: CA$1.13m (loss narrowed 5.0% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Board Change • Jul 31High number of new directorsIndependent Director Mark Kohler was the last director to join the board, commencing their role in 2021.Recent Insider Transactions • Apr 20Independent Director recently sold €49k worth of stockOn the 13th of April, Jim Molyneux sold around 188k shares on-market at roughly €0.26 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €222k more than they bought in the last 12 months.Is New 90 Day High Low • Feb 06New 90-day high: €0.30The company is up 66% from its price of €0.18 on 06 November 2020. The German market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 26% over the same period.Reported Earnings • Feb 01Full year 2020 earnings released: CA$0.078 loss per share (vs CA$0.037 loss in FY 2019)The company reported a solid full year result with improved revenues and control over costs, although losses increased. Full year 2020 results: Revenue: CA$288.9k (up 397% from FY 2019). Net loss: CA$6.72m (loss widened 132% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Jan 09New 90-day high: €0.28The company is up 49% from its price of €0.19 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period.Is New 90 Day High Low • Dec 23New 90-day high: €0.24The company is up 36% from its price of €0.18 on 24 September 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period.株主還元1UR1DE ChemicalsDE 市場7D0%-1.6%3.4%1Y-88.2%5.5%3.4%株主還元を見る業界別リターン: 1UR1過去 1 年間で5.5 % の収益を上げたGerman Chemicals業界を下回りました。リターン対市場: 1UR1は、過去 1 年間で3.4 % のリターンを上げたGerman市場を下回りました。価格変動Is 1UR1's price volatile compared to industry and market?1UR1 volatility1UR1 Average Weekly Movementn/aChemicals Industry Average Movement5.7%Market Average Movement6.0%10% most volatile stocks in DE Market12.5%10% least volatile stocks in DE Market2.7%安定した株価: 1UR1の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間の1UR1のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aAshish Malikwww.beevt.comビー・ベクタリング・テクノロジーズ・インターナショナル社は、害虫の防除、および生物学的防除による農作物や観葉植物の強化に焦点を当て、米国で様々な応用プロセスを展開している。同社のソリューションは、接種剤ディスペンサー・システム「ハイブ＆ビーズ」、取り外し可能で使いやすいトレイ「ベクターパック」、さまざまな天然素材から特別に調合された特許取得済みパウダー「ベクターライト」、天然に存在する内生菌の有機菌株「BVT-CR7」などの有効成分、花粉分配システムで構成されている。同社の特許および特許出願中の技術は、有機化合物からなる様々な粉末混合物や、一般的な作物の病害を抑制・除去する使用製品の自然な送達メカニズムとしてミツバチを利用している。同社はまた、イチゴ、ヒマワリ、リンゴ、トマト、キャノーラ作物、ブルーベリーなど、さまざまな作物に自然な害虫・病害管理ソリューションを提供している。本社はカナダのミシサガ。もっと見るBee Vectoring Technologies International Inc. 基礎のまとめBee Vectoring Technologies International の収益と売上を時価総額と比較するとどうか。1UR1 基礎統計学時価総額€663.79k収益（TTM）-€2.97m売上高(TTM)€73.80k9.0xP/Sレシオ-0.2xPER（株価収益率1UR1 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計1UR1 損益計算書（TTM）収益CA$115.21k売上原価CA$12.82k売上総利益CA$102.39kその他の費用CA$4.73m収益-CA$4.63m直近の収益報告Jun 30, 2024次回決算日該当なし一株当たり利益（EPS）-0.022グロス・マージン88.87%純利益率-4,018.68%有利子負債／自己資本比率56.1%1UR1 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/05/04 12:52終値2025/02/04 00:00収益2024/06/30年間収益2023/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bee Vectoring Technologies International Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Featured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.0% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.8kusers have viewed this narrative41users have liked this narrative1users have commented on this narrative284users have followed this narrativeRead narrative
Board Change • Dec 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Gustavo Gonzalez was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2023)Third quarter 2024 results: CA$0.006 loss per share (in line with 3Q 2023). Net loss: CA$1.18m (loss widened 41% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.
お知らせ • Aug 22Bee Vectoring Technologies International Inc. Receives Mexican Approval on its Proprietary Biological for Commercial UseBee Vectoring Technologies International Inc. announced the Company's proprietary Vectorite with Clonostachys Rosea CR-7 (CR-7) has been approved by Mexico's COFEPRIS (The Federal Commission for Protection from Sanitary Risks), the country's health authority responsible for registration of plant protection products, for use as a fungicide on commercial crops. The approval covers delivery of CR-7 using both bumble bees and honeybees on various high value crops, including the berry group of crops and indoor vegetables. Mexico's growers offer significant market potential for BVT's natural precision agriculture system: official statistics indicate that the country's production in 2019 included 41,600 acres of strawberries, 12,100 acres of blueberries and over 377,000 acres of tomatoes and peppers.(1) In the same year, US imports of fresh and processed fruits and vegetables from Mexico amounted to USD 15.6 billion. The country uses USD 1.3 billion worth of pesticides each year, but an increasing number of growers are turning to biologicals as an alternative that offers better quality, greater food safety and reduces the need for chemicals. Mexico's COFEPRIS registration makes Vectorite with CR-7 available immediately for sale as a registered fungicide for use on the labelled crops.
Reported Earnings • Jun 04Second quarter 2024 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2023). Revenue: CA$81.9k (down 77% from 2Q 2023). Net income: CA$20.9k (up CA$567.2k from 2Q 2023). Profit margin: 26% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 03First quarter 2024 earnings released: CA$0.011 loss per share (vs CA$0.011 loss in 1Q 2023)First quarter 2024 results: CA$0.011 loss per share (in line with 1Q 2023). Revenue: CA$17.0k (down 62% from 1Q 2023). Net loss: CA$1.65m (loss widened 12% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 53% per year, which means it is significantly lagging earnings.
お知らせ • Mar 02Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024. Location: Suite 1890 1075 West Georgia Street Vancouver British Columbia Canada
Board Change • Dec 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Gustavo Gonzalez was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2023)Third quarter 2024 results: CA$0.006 loss per share (in line with 3Q 2023). Net loss: CA$1.18m (loss widened 41% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.
お知らせ • Aug 22Bee Vectoring Technologies International Inc. Receives Mexican Approval on its Proprietary Biological for Commercial UseBee Vectoring Technologies International Inc. announced the Company's proprietary Vectorite with Clonostachys Rosea CR-7 (CR-7) has been approved by Mexico's COFEPRIS (The Federal Commission for Protection from Sanitary Risks), the country's health authority responsible for registration of plant protection products, for use as a fungicide on commercial crops. The approval covers delivery of CR-7 using both bumble bees and honeybees on various high value crops, including the berry group of crops and indoor vegetables. Mexico's growers offer significant market potential for BVT's natural precision agriculture system: official statistics indicate that the country's production in 2019 included 41,600 acres of strawberries, 12,100 acres of blueberries and over 377,000 acres of tomatoes and peppers.(1) In the same year, US imports of fresh and processed fruits and vegetables from Mexico amounted to USD 15.6 billion. The country uses USD 1.3 billion worth of pesticides each year, but an increasing number of growers are turning to biologicals as an alternative that offers better quality, greater food safety and reduces the need for chemicals. Mexico's COFEPRIS registration makes Vectorite with CR-7 available immediately for sale as a registered fungicide for use on the labelled crops.
Reported Earnings • Jun 04Second quarter 2024 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2023). Revenue: CA$81.9k (down 77% from 2Q 2023). Net income: CA$20.9k (up CA$567.2k from 2Q 2023). Profit margin: 26% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 03First quarter 2024 earnings released: CA$0.011 loss per share (vs CA$0.011 loss in 1Q 2023)First quarter 2024 results: CA$0.011 loss per share (in line with 1Q 2023). Revenue: CA$17.0k (down 62% from 1Q 2023). Net loss: CA$1.65m (loss widened 12% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 53% per year, which means it is significantly lagging earnings.
お知らせ • Mar 02Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024. Location: Suite 1890 1075 West Georgia Street Vancouver British Columbia Canada
お知らせ • Feb 01Bee Vectoring Technologies International Inc. Announces Paid Demonstration Trials in Mexico with Major Multi-National GrowerBee Vectoring Technologies International Inc. announced that a major multi-national grower is conducting demonstration trials in Mexico with BVT's proprietary Vectorite with CR-7 (Clonostachys rosea CR-7) biological fungicide and natural precision agriculture system. This multi-national grower is a key producer of blueberries, raspberries, blackberries and table grapes in Mexico. They have over 5,000 hectares worldwide for the production of berries, with additional operations in the US, Peru and Morocco. After the initial honeybee system trials in their Mexican operations, there is opportunity to expand BVT trials to the other countries. The BVT trials are staggered to the start of bloom time for each berry crop. They commenced last September with the start of blackberry and raspberry bloom periods, moved to blueberry in November, and lasts into early 2024. Trial data is being collected at each crop's harvest time and the grower is currently evaluating for yield performance and percentage of fruit spoilage with BVT and the grower standard applied versus the grower standard used alone. Geographic expansion is a key element in BVT's ongoing corporate expansion strategy. BVT's registration dossier was submitted to regulatory authorities in Mexico in April 2022, and BVT continues to build and expand strategic relationships with Mexican growers. This newest relationship with a multi-national grower with operations in Mexico is a vital step in the Company's continued development in the country.
Reported Earnings • Jan 30Full year 2023 earnings released: CA$0.034 loss per share (vs CA$0.041 loss in FY 2022)Full year 2023 results: CA$0.034 loss per share (improved from CA$0.041 loss in FY 2022). Revenue: CA$601.6k (up 21% from FY 2022). Net loss: CA$4.67m (loss narrowed 5.2% from FY 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 55% per year, which means it is significantly lagging earnings.
お知らせ • Jan 17Bee Vectoring Technologies International Inc. Announces South African Trials with Major Multi-National AgribusinessBee Vectoring Technologies International Inc. announced South African multi-national agricultural technology business Microbial Biological Fertilizers International (MBFi) has commenced trials of BVT products in South Africa. They will be evaluating BVT's patented bee vectoring dispenser for honeybees with proprietary Vectorite powder, initially testing with MBFi's own biological strain as a comparison with traditional spray applications. MBFi manufactures agricultural products for the South African farming industry, supplying fertilizer, biostimulants, biologicals and adjuvants. Trials are being conducted on grower crop fields including macadamias, avocados, apples, strawberries, blueberries and cherries, timed for the start of each crop's bloom period. MBFi will also extend the trials to include sunflowers and canola. In South Africa, macadamia, avocado, applies, strawberries, blueberries and cherry crops cover over 85,000 hectares of farmland, with sunflowers and canola adding another 520,000.
Reported Earnings • Sep 03Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.008 loss in 3Q 2022)Third quarter 2023 results: CA$0.006 loss per share (improved from CA$0.008 loss in 3Q 2022). Revenue: CA$203.2k (up 32% from 3Q 2022). Net loss: CA$836.2k (loss narrowed 9.7% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.013 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (improved from CA$0.013 loss in 2Q 2022). Revenue: CA$360.6k (up 26% from 2Q 2022). Net loss: CA$546.3k (loss narrowed 64% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
お知らせ • May 16Bee Vectoring Technologies International Inc. announced that it has received CAD 0.27 million in fundingOn May 15, 2023, Bee Vectoring Technologies International Inc. closed the transaction. All securities issued pursuant to the transaction are subject to a statutory hold period which will expire on September 13, 2023 in accordance with applicable securities laws of Canada.
Reported Earnings • Mar 03First quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.009 loss in 1Q 2022)First quarter 2023 results: CA$0.011 loss per share (further deteriorated from CA$0.009 loss in 1Q 2022). Revenue: CA$44.5k (up 11% from 1Q 2022). Net loss: CA$1.48m (loss widened 37% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.
Board Change • Dec 30Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Jim Molyneux was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 19Bee Vectoring Technologies International Inc., Annual General Meeting, Jan 19, 2023Bee Vectoring Technologies International Inc., Annual General Meeting, Jan 19, 2023.
Reported Earnings • Jan 30Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: CA$0.036 loss per share (up from CA$0.078 loss in FY 2020). Revenue: CA$399.1k (up 38% from FY 2020). Net loss: CA$4.12m (loss narrowed 39% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Reported Earnings • Sep 01Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.013 loss in 3Q 2020)Third quarter 2021 results: Net loss: CA$1.13m (loss narrowed 5.0% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Board Change • Jul 31High number of new directorsIndependent Director Mark Kohler was the last director to join the board, commencing their role in 2021.
Recent Insider Transactions • Apr 20Independent Director recently sold €49k worth of stockOn the 13th of April, Jim Molyneux sold around 188k shares on-market at roughly €0.26 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €222k more than they bought in the last 12 months.
Is New 90 Day High Low • Feb 06New 90-day high: €0.30The company is up 66% from its price of €0.18 on 06 November 2020. The German market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 26% over the same period.
Reported Earnings • Feb 01Full year 2020 earnings released: CA$0.078 loss per share (vs CA$0.037 loss in FY 2019)The company reported a solid full year result with improved revenues and control over costs, although losses increased. Full year 2020 results: Revenue: CA$288.9k (up 397% from FY 2019). Net loss: CA$6.72m (loss widened 132% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Jan 09New 90-day high: €0.28The company is up 49% from its price of €0.19 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period.
Is New 90 Day High Low • Dec 23New 90-day high: €0.24The company is up 36% from its price of €0.18 on 24 September 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period.
